Patents Assigned to Canterbury Health Limited
  • Dendritic cell-specific antibodies and method for their preparation
    Patent number: 5876917
    Abstract: This invention describes methods for generating antibodies specific for activation antigen CMRF-44 on activated dendritic cells, and antibodies produced by the method. The use of such antibodies, including monoclonal antibody CMRF-44, in immunological-based processes and systems for purifying and/or identifying activated dendritic cells is also described.
    Type: Grant
    Filed: May 6, 1996
    Date of Patent: March 2, 1999
    Assignee: Canterbury Health Limited
    Inventor: Derek N. J. Hart